Literature DB >> 8695678

The relationship between Piaget and cognitive levels in persons with Alzheimer's disease and related disorders.

M A Matteson1, A D Linton, S J Barnes, B L Cleary, M J Lichtenstein.   

Abstract

Clinical observations and research studies have documented that people with Alzheimer's disease and related disorders (ADRD) appear to regress developmentally during the course of the disease. The purpose of this study was to prospectively determine the association between changes in Piaget levels of cognitive development and cognitive decline in nursing home residents in various stages of ADRD. Fifty-seven people were tested three times at yearly intervals, using the Folstein Mini-Mental State Exam to determine cognitive levels and a set of 14 Piaget tasks to determine cognitive developmental levels: 1) Formal Operations; 2) Concrete Operations; 3) Preoperational; and 4) Sensorimotor. Mean MMSE scores declined from 12.7 to 9.4, and there was a downward trend in Piaget levels over the study period. ANOVA showed significant differences (p < 0.0005, Years 1, 2, 3) in MMSE scores among all Piaget levels, and Spearman rho analysis showed significant correlations between Piaget levels and MMSE for each year (p < 0.0005, Years 1, 2, 3). The results suggest that there is a concurrent decline in cognitive developmental levels and cognition in people in various stages of Alzheimer's disease and related disorders.

Entities:  

Mesh:

Year:  1996        PMID: 8695678     DOI: 10.1007/bf03340117

Source DB:  PubMed          Journal:  Aging (Milano)        ISSN: 0394-9532


  2 in total

1.  Conservation of species, volume, and belief in patients with Alzheimer's disease: the issue of domain specificity and conceptual impairment.

Authors:  Deborah Zaitchik; Gregg E A Solomon
Journal:  Cogn Neuropsychol       Date:  2009-09       Impact factor: 2.468

2.  Effectiveness of different memory training programs on improving hyperphagic behaviors of residents with dementia: a longitudinal single-blind study.

Authors:  Chieh-Chun Kao; Li-Chan Lin; Shiao-Chi Wu; Ker-Neng Lin; Ching-Kuan Liu
Journal:  Clin Interv Aging       Date:  2016-05-23       Impact factor: 4.458

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.